CompletedNot Applicable

A Combined Supplementation of Rosemary and Daylily for Enhancing Sleep Quality in Middle-Aged Adults

Serbia10 participantsStarted 2025-04-15

Plain-language summary

This study aims to investigate the impact of supplementation with two different doses of Rosemary and Daylily herbal extract on various health outcomes in middle-aged adults. Over an eight-week period, the trial will assess improvements in sleep quality, circadian rhythms, energy metabolism, and relevant biochemical markers. The study employs a randomized, placebo-controlled, crossover design to evaluate the efficacy of these supplements in enhancing overall health and well-being.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 50 years * Trouble falling asleep \> 5 times a month (NHANES criteria) * Body mass index 18.5-29.9 kg/m2 * Free of major chronic diseases or acute disorders * Given written informed consent Exclusion Criteria: * History of dietary supplement use \> 2 weeks before the study commences * Abnormal values for lab clinical chemistry (\> 2 SD) * Unwillingness to return for follow-up analysis * Participation in other clinical trials * Moderate-to-heavy use of alcohol (\> 3 drinks per week)

What they're measuring

Total sleep time

Timeframe: Change from baseline total sleep time at 8 weeks

Trial details

NCT IDNCT06859879

SponsorUniversity of Novi Sad, Faculty of Sport and Physical Education

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-30

View on ClinicalTrials.gov More Sleep trials